Ozempic, Wegovy linked to severe medical conditions ... - NBC News
WEBPeople who take popular drugs for weight loss, like Ozempic or Wegovy, may be at an increased risk of severe stomach issues, research published Thursday finds.
Ozempic reduces risk of serious illness and death in people with ... - CNN
WEBMay 24, 2024 · Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEBWegovy (semaglutide) injection is the first weight loss medication to also prevent cardiovascular events in adults with obesity or overweight and cardiovascular disease. It is approved by the...
Research Leading to Ozempic Honored by 2024 Lasker Awards
WEB1 day ago · Research That Led to Obesity Drugs Wins Major Medical Prize. Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V ...
Drug in Ozempic may enable patients with newly diagnosed type …
WEBSep 8, 2023 · A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after...
Ozempic May Help Treat Kidney Disease, Study Finds - The New York Times
WEBMay 24, 2024 · Semaglutide, the compound in the blockbuster drugs Ozempic and Wegovy, dramatically reduced the risk of kidney complications, heart issues and death in people with Type 2 diabetes and chronic...
Ozempic may be linked to condition that causes blindness ... - NBC News
WEBJul 3, 2024 · People taking Ozempic and Wegovy may be at increased risk of developing a debilitating eye condition that can cause irreversible vision loss, a study published Wednesday in JAMA Ophthalmology...
Wegovy Approved By FDA to Reduce Heart Attack Risk - The New York Times
WEBMar 11, 2024 · Compounded Semaglutide: Here’s what to know about the overdose risks of the Ozempic alternative.
Ozempic could curb progression of diabetes-linked liver disease
WEB4 days ago · One GLP-1 med, semaglutide (Ozempic/Wegovy), seemed especially potent in this regard, according to a team led by Dr. Fasiha Kanwal, a professor of gastroenterology at Baylor College of Medicine in ...
As Ozempic’s Popularity Soars, Here’s What to Know About Semaglutide …
WEBLearn about semaglutide, a GLP-1 agonist that is used to treat type 2 diabetes and obesity, and its popularity as Ozempic. Read the JAMA article and commentary that review the evidence, benefits, and risks of this drug.
Skip to content